AHPA continues to follow new COVID-19 regulations, guidance and other government actions. The updates below are the latest guidance and other developments since May 1, 2021 to help mitigate the impacts of COVID-19. For earlier COVID-19 regulations and guidance, visit the previous Policy Briefs.

FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine for Emergency Use in Adolescents
The FDA has expanded the Emergency Use Authorization (EUA) for the Pfizer-BioNTech COVID-19 vaccine to include adolescents 12 through 15 years of age.

CMS Expanding Efforts to Grow COVID-19 Vaccine Confidence and Protect Residents
CMS has issued a rule that will ensure long-term care and residential facilities serving clients with intellectual disabilities educate and offer COVID-19 vaccines to residents, clients and staff.